Clinical Trials Logo

Myocardial Ischemia clinical trials

View clinical trials related to Myocardial Ischemia.

Filter by:

NCT ID: NCT01511120 Completed - Clinical trials for Coronary Heart Disease

The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols

Start date: November 2011
Phase: Phase 2
Study type: Interventional

"The impact on fluid loading after cardiac surgery by use of two different priming solution" Fluid overloading with oedema formation is a regular finding following on-pump cardiac surgery and may contribute to postoperative organ dysfunction. Myocardial oedema has been reported to impair both systolic and diastolic function. An association between intraoperative fluid loading and postoperative adverse outcome has been demonstrated in cardiac patients. The investigators have experience with the use of both colloides and combination fluids (hypertonic saline/colloides) in several experimental studies (pigs). In one animal study the investigators used colloides as an additive to the CPB-prime. The investigators observed reduced fluid leakage and less total tissue water in several organs. The planned study includes patients scheduled for coronary artery bypass, and who have no co-morbidity. The patients will be randomized to receive either Tetraspan® (HES) or acetated Ringer`s solution in the CPB-prime. Accurate accounts of fluid additions, blood loss and diuresis will be kept. Determination of cardiac output (C.O.), intrathoracic blood volume (ITBV), extravascular lung water (EVLW) and global end diastolic volume (GEDV) will be monitored by use of the transpulmonary thermodilution technique PiCCO®plus system.

NCT ID: NCT01510327 Completed - Clinical trials for Coronary Artery Disease

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

PLATINUM PK
Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Elementâ„¢ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions are located in vessels that are average-sized.

NCT ID: NCT01508910 Completed - Clinical trials for Refractory Angina Pectoris

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

RENEW
Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety and efficacy of targeted intramyocardial delivery of Auto-CD34+ cells for increasing exercise time and amelioration of anginal symptoms in subjects with refractory angina and chronic myocardial ischemia.

NCT ID: NCT01508663 Recruiting - Clinical trials for Coronary Artery Disease

The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease

BRAVE
Start date: August 2010
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to determine whether PCI added to OMT could be superior over OMT alone in the prevention of late adverse cardiac and cerebro-vascular events in elderly patients with coronary artery disease (CAD) during the additional 12 months.

NCT ID: NCT01507805 Recruiting - Clinical trials for Coronary Heart Disease

Electroacupuncture Preconditioning on Geriatric Noncardiac Surgery

Start date: February 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to observe whether the electroacupuncture (EA) preconditioning for five days before operation can improve the outcomes of patients with coronary heart disease undergoing geriatric non-cardiac surgery.

NCT ID: NCT01507519 Completed - Clinical trials for Coronary Artery Disease

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions

meriT-1
Start date: April 2009
Phase: N/A
Study type: Interventional

1.) Indigenously developed and designed BioMimeTM is a - predictably safe & efficacious 3rd generation drug eluting stent (DES) - with a propensity to minimize vascular injury by use of an intelligent mix of ultra-low strut thickness Co-Cr stent, - highly documented drug Sirolimus & - a biocompatible, biodegradable polymer

NCT ID: NCT01506999 Recruiting - Clinical trials for Myocardial Infarction

Genetic Mapping for Cardiac Risk Assessment

GENOCOR
Start date: July 2006
Phase: N/A
Study type: Observational

The main objective of the GENOCOR project (Genetic mapping for cardiac risk assessment) is the setting up of a joint public/private laboratory (GENOCOR-LAB) dedicated to the development and testing of new cost-effective technologies exploiting the growing knowledge in the genomic correlates of cardiovascular diseases (CVD) and of their evolution; the data obtained by the GENOCOR-Lab should especially orient secondary prevention and specific treatment of ischemic heart diseases (IHD).

NCT ID: NCT01506960 Terminated - Clinical trials for Coronary Artery Disease

Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque

Start date: January 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to learn more about lipid rich plaque using Near Infrared Spectroscopy (NIRS)/Intravascular Ultrasound (IVUS) imaging in patients who have had coronary artery stenting and Optical coherence tomography (OCT) imaging.

NCT ID: NCT01504945 Terminated - Anemia Clinical Trials

Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

Start date: February 2010
Phase: Phase 1/Phase 2
Study type: Interventional

Patients with a low blood count (anemia) with stable or unstable coronary artery disease consistently show worse clinical outcomes. It is unclear whether this association is confounded since anemic patients tend to be also sicker i.e. have lower ejection fractions or more comorbidities and this would be the reason for the worse outcomes rather than anemia. The coronary arteries are a unique vascular bed insofar that across the cardiac circulation oxygen extraction is close to maximal at rest. Thus increases in demand can only be met by increases in blood flow and hemoglobin concentration since oxygen extraction is maximal at rest. It is natural to assume that maximization of oxygen delivery in the setting of active coronary syndrome (ACS) is beneficial to the patient since oxygen extraction and coronary blood flow is fixed. In fact, in most intensive care units patients with ACS are transfused to a HCT of 30%. However, retrospective analysis of trial data showed at best mixed results in clinical outcome when patients with ACS were transfused and in fact in some studies showed consistently worse outcomes than non-transfused patients. Similar disappointing results have recently published in patient who underwent coronary artery bypass grafting (CABG). This study is designed to determine the effect of red blood cell (RBC) transfusion on oxygen consumption, cardiac, microcirculatory and endothelial function in patients with active coronary artery disease. For this study active coronary artery disease will be defined as the patient having undergone within the past 4 days of recruitment either a myocardial infarction due to atherothrombosis (AHA type I myocardial infarction) or surgery for coronary artery bypass grafting. In specific this study will test the hypothesis whether RBC transfusions improves cardiac and vascular function in patients with a hematocrit of less than 30% with active coronary artery disease. Aims of this study are to determine whether RBC transfusion in patients with active coronary artery disease and anemia: - increases oxygen delivery to the peripheral tissues. - increases whole-body oxygen consumption. - decreases nitric oxide bioavailability, endothelial, microcirculatory, and myocardial function, and/or increases platelet aggregation

NCT ID: NCT01504269 Completed - Clinical trials for Coronary Artery Disease

Exercise Stress CMR Comparison Study

Start date: August 2007
Phase: N/A
Study type: Interventional

This study is being done to compare standard nuclear exercise stress testing to exercise stress magnetic resonance imaging (MRI). The investigators have successfully shown that exercise MRI works well in healthy volunteers, and the next step is to test if it works as well as nuclear stress testing in patients with known or suspected heart disease. MRIs offers superior image quality compared to echocardiography and nuclear imaging, and have the ability to image both function and perfusion. Combining the superior image quality of Cardiac MRI with the diagnostic information provided by exercise stress could result in a new, more accurate modality for diagnosing and evaluating coronary artery disease.